UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-A

 

FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES

PURSUANT TO SECTION 12(b) OR 12(g) OF

THE SECURITIES EXCHANGE ACT OF 1934

 

BIOFRONTERA INC.

(Exact name of registrant as specified in its charter)

 

Delaware   47-3765675

(State of Incorporation

or Organization)

 

(I.R.S. Employer

Identification No.)

 

     

120 Presidential Way, Suite 330

Woburn, MA

  01801
(Address of Principal Executive Offices)   (Zip Code)

 

Securities to be registered pursuant to Section 12(b) of the Act:

 

Title of Each Class

to be so Registered

 

Name of Each Exchange on Which

Each Class is to be Registered

Common Stock, par value $0.001 value per share   The Nasdaq Stock Market LLC

 

If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), please check the following box. ☒

 

If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), please check the following box. ☐

 

If this form relates to the registration of a class of securities with a Regulation A offering, check the following box. ☐

 

Securities Act registration statement file number to which this form relates: 333-257722

 

Securities to be registered pursuant to Section 12(g) of the Act: None.

 

 

 

 

 

 

Item 1: Description of Registrant’s Securities to be Registered

 

The description of the common stock, par value $0.001 per share (the “Common Stock”), of Biofrontera Inc. (the “Company”), to be registered hereunder is contained in the section titled “Description of Capital Stock” in the prospectus forming a part of the Company’s Registration Statement on Form S-1 (File No. 333-257722), as originally filed with the Securities and Exchange Commission on July 6, 2021, as thereafter amended and supplemented from time to time, including any form of prospectus contained therein pursuant to Rule 424(b) under the Securities Act of 1933, as amended, is incorporated by reference herein.

 

Item 2: Exhibits

 

Pursuant to the Instructions as to Exhibits with respect to Form 8-A, no exhibits are required to be filed because no other securities of the Company are listed on The Nasdaq Stock Market LLC and the securities registered hereby are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended.

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.

 

 

  BIOFRONTERA INC.
     
  By: /s/ Erica L. Monaco
  Name: Erica L. Monaco
  Title: Chief Financial Officer and Chief Operating Officer

 

Date: October 20, 2021